Permian Resources Corporation reports Q1 2026 results on May 5 with the Street unusually aligned — a flurry of target price raises over the past six weeks has pushed the analyst consensus firmly into bullish territory heading into the release.
The analyst move has been the standout story for PR this spring. Wells Fargo lifted its target from $21 to $27 on April 10, keeping an Overweight rating. Scotiabank raised from $21 to $25 on April 22 while reiterating Sector Outperform. Truist bumped its target to $25, and Citi had already moved to $26 in late March. Against a mean target of $25.20 and a current price of $22.10, the Street sees roughly 14% upside — and Keybanc's April 7 Overweight initiation at $25 adds fresh conviction to that view. The only discordant note came from Roth Capital, which downgraded to Neutral on April 8, citing execution risk, a lone voice against the prevailing upgrade tide.
The bull case centres on volume growth of 3–4%, new midstream contracts lifting oil realizations toward 99% of WTI, and free cash flow generation contingent on oil staying above $70 per barrel. Bears point to underwhelming well productivity, lingering questions about synergy capture from recent acquisitions, and the ever-present exposure to commodity price weakness. The EV/EBITDA multiple of 4.5x has compressed roughly 8% over the past 30 days — a modest de-rating even as the stock climbed, which is consistent with the Street concluding that the valuation case is improving, not eroding.
Options positioning adds texture. The put/call ratio has dropped to 0.19, well below its 20-day mean of 0.24 and near the lowest level of the past year — suggesting options traders have rotated heavily toward calls and are leaning bullish into the print. Short interest is a non-story here: at 2.6% of free float, with a cost to borrow of just 0.35% and very loose availability (utilization below 2%), there is no meaningful short pressure in the lending market. Short interest did rise about 16% over the past month, but the absolute level remains too low to signal any conviction among skeptics.
The insider picture is a mild counterpoint. Both Co-CEOs — William Hickey and James Walter — sold shares in early March at around $18.38, alongside selling from a board director and the general counsel. The combined net selling over the 90-day window reached roughly $89 million. The sales predated the stock's 20% subsequent rally to $22.10 and may reflect pre-planned disposals, but they leave a visible contrast against the bullish analyst backdrop.
May 5's print will test whether the operational momentum the Street has been pricing in — volume growth, improving realizations, and early synergy delivery — holds up against a commodity price backdrop that remains volatile.
See the live data behind this article on ORTEX.
Open PR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
